Scholar Rock Holding Corporation (FRA:2QK)

Germany flag Germany · Delayed Price · Currency is EUR
38.40
+1.40 (3.78%)
Last updated: Dec 5, 2025, 8:10 AM CET
5.49%
Market Cap 3.95B
Revenue (ttm) n/a
Net Income (ttm) -301.23M
Shares Out n/a
EPS (ttm) -3.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 19
Open 38.40
Previous Close 37.00
Day's Range 38.40 - 38.40
52-Week Range 21.20 - 46.00
Beta n/a
RSI 66.08
Earnings Date Feb 27, 2026

About Scholar Rock Holding

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFβ) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 128
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2QK
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.